You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
千金藥業(600479.SH):公司沒有千金藤素的生產及銷售
格隆匯 05-16 16:53

格隆匯5月16日丨千金藥業(600479.SH)公佈關於股票交易異常波動的公吿,公司股票連續三個交易日內收盤價格漲幅偏離值累計超過 20%,根據《上海證券交易所交易規則》的有關規定,屬於股票交易異常波動。

經公司自查並向控股股東及實際控制人核實,截至公吿披露日,除公司已披露事項外,不存在應披露而未披露的重大事項。

針對公司股票交易波動異常的情況,公司關注到部分投資者認為近日《我國科學家發現的新冠治療新藥獲得國家發明專利授權》有關報道中的千金藤素與公司有關,現將有關情況説明如下:

公司沒有千金藤素的生產及銷售,公司主要產品婦科千金片中主要成分黃藤素是乾燥藤莖中提取得到的生物鹼;千金藤素是從防己科植物頭花千金藤、地不容中分離提取的雙節基異喹啉生物鹼。兩者不是同一種物質,在化學結構、藥理作用方面存在較大差異。

經自查,目前尚未發現公共傳媒報道可能或已經對公司股票交易價格產生較大影響的未公開重大信息。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account